InsidersTradesSigma
Follow the Fortress Biotech, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Fortress Biotech, Inc. has published 80 public disclosures. Market capitalisation: €111m. The latest transaction was reported on 24 June 2026 (Attribution). Among the most active insiders: ROSENWALD LINDSAY A MD. Every trade is accessible without an account.
80
Insider Decl.
n/a
Thresholds
€8m
22 ops.
Buy Volume
€92,941
2 ops.
Sell Volume
42Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,306 of 28,857 companies
40.7
score / 100
Value14
Quality68
FCF yld-67%
Earn yld-1.9%
EV/EBITDA·
ROE116%
Gross mgn67%
Net mgn-3.0%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 June 2026
Declarations80 total
475,424 shares0common stock, par value $0.001SEC:0001038977-26-000002:0
475,424 shares0Common stock, par value $0.001SEC:0000941841-26-000002:0
27,322 shares0common stock, par value $0.001SEC:0001772558-26-000002:0
27,322 shares0common stock, par value $0.001SEC:0001529687-26-000002:0
27,322 shares0Common Stock, par value $0.001SEC:0001294517-26-000002:0
27,322 shares0common stock, par value $0.001SEC:0001172659-26-000002:0
49,383 shares0Common Stock, par value $0.001SEC:0001415889-25-000425:0
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000444:0
454,153 shares0common stock, par value $0.001SEC:0001415889-25-000402:0
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000427:0
454,153 shares0Common stock, par value $0.001SEC:0001415889-25-000400:0
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000426:0
763,359 shares@ US$1.8420.5% of flowCommon stock, par value $0.001SEC:0001415889-24-023957:0
Canonical exit: 22 Dec 2024 (T+90)
5,000 shares@ US$7.48350.6% of flowSERIES A CUMULATIVE PERPETUAL PREFERRED STOCKSEC:0001104659-24-079855:0
Canonical exit: 9 Oct 2024 (T+90)
5,000 shares@ US$7.39420.6% of flowSERIES A CUMULATIVE PERPETUAL PREFERRED STOCKSEC:0001104659-24-079100:0
Canonical exit: 7 Oct 2024 (T+90)
25 of 80 declarations
About Fortress Biotech, Inc.
Fortress Biotech, Inc. is a company focused on developing innovative therapies for the treatment of diseases. It primarily operates in the healthcare and pharmaceutical sector, listed on NASDAQ.